Company Encyclopedia
View More
name
Pacific Biosc California
PACB.US
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides.
770.89 B
PACB.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
E
Life Sciences Tools and ServicesIndustry
Industry Ranking60/60
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-205.90%E
    • Profit Margin-325.80%E
    • Gross Margin42.04%B
  • Growth ScoreE
    • Revenue YoY-10.72%D
    • Net Profit YoY-27.75%D
    • Total Assets YoY-44.61%E
    • Net Assets YoY-92.04%E
  • Cash ScoreD
    • Cash Flow Margin-30.69%D
    • OCF YoY-10.72%D
  • Operating ScoreE
    • Turnover0.14E
  • Debt ScoreE
    • Gearing Ratio95.51%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More